Pi Health is building the AI-native operating system for global drug development. Our platform, FICS®, delivers breakthrough efficiencies, accelerates timelines, and ensures the highest data quality in clinical trials—empowering pharmaceutical companies and health systems to bring life-changing treatments to patients faster than ever before. With a global team and a technology-integrated site network spanning five continents, Pi Health is committed to expanding access to innovative medicines and ensuring that patients around the world can participate in cutting-edge clinical research.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pi Health, a global health technology and clinical research company, today announced it will provide fully outsourced clinical research services in a GSK clinical trial with the aim of significantly improving the time and efficiency of the clinical trial process. Pi Health and GSK have executed a Master Clinical Services Outsourcing Agreement for the collaboration and have begun initial activities for a global Phase 2 oncology clinical trial.